Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


I got back my final lab results today. We were mainly looking for two things. First, the volume of the antibody that corresponds to the particular type of blood plasma cell that had become cancerous. In my case, that’s the IgG antibody, and over the course of the chemotherapy its volume has fallen from 6200 to 1580. This puts it—barely!—within the normal range. Second, the level of a protein marker that tells us what percentage of my plasma cells are healthy vs. cancerous. This has gone down from 4.2 to 1.18. Ideally I think it would be closer to zero than that, but it’s still a pretty good number.

Bottom line: the first stage of my chemotherapy has been successful and is now over. Hooray! The side effects are going to linger for a while, but hopefully not for more than a month or so. At that point, I’ll be ready for stage 2, which is an autologous stem cell transplant—that is, a procedure in which they draw out stem cells from my blood and then transplant them back into my body later. You can google the gory details if you really want them.

That will all happen in about a month or so, and will probably put me out of commission for a couple of weeks. In the meantime, I get several weeks of recovery time along with a whole bunch of pre-op workups. Should be loads of fun.

But the important thing is that stage 1 is over and I’m basically in remission. I’m now crossing my fingers and hoping that stage 2 is equally successful.

We've never been very good at being conservative.

And usually, that serves us well in doing the ambitious, hard-hitting journalism that you turn to Mother Jones for. But it also means we can't afford to come up short when it comes to scratching together the funds it takes to keep our team firing on all cylinders, and the truth is, we finished our budgeting cycle on June 30 about $100,000 short of our online goal.

This is no time to come up short. It's time to fight like hell, as our namesake would tell us to do, for a democracy where minority rule cannot impose an extreme agenda, where facts matter, and where accountability has a chance at the polls and in the press. If you value our reporting and you can right now, please help us dig out of the $100,000 hole we're starting our new budgeting cycle in with an always-needed and always-appreciated donation today.

payment methods

We've never been very good at being conservative.

And usually, that serves us well in doing the ambitious, hard-hitting journalism that you turn to Mother Jones for. But it also means we can't afford to come up short when it comes to scratching together the funds it takes to keep our team firing on all cylinders, and the truth is, we finished our budgeting cycle on June 30 about $100,000 short of our online goal.

This is no time to come up short. It's time to fight like hell, as our namesake would tell us to do, for a democracy where minority rule cannot impose an extreme agenda, where facts matter, and where accountability has a chance at the polls and in the press. If you value our reporting and you can right now, please help us dig out of the $100,000 hole we're starting our new budgeting cycle in with an always-needed and always-appreciated donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate